参考文献：

［1］AEPPLI T R,RYMEN D,ALLEGRI G,et al.Glycogen storage disease type VI:clinical course and molecular background［J］. Eur J Pediatr,2020,179（3）:405-413.

［2］KIDO J,NAKAMURA K,MATSUMOTO S,et al.Current status of hepatic glycogen storage disease in Japan:clinical manifestations,treatments and long—term outcomes［J］.Hum Genet,2013,58（5）:285-292.

［3］KISHNANI P S,GOLDSTEIN J,AUSTIN S L,et al. ACMG Work Group on Diagnosis and Management of Glycogen Storage Diseases Type VI and IX. Diagnosis and management of glycogen storage diseases type VI and IX:a clinical practice resource of the American College of Medical Genetics and Genomics （ACMG）.Genet Med,2019,21（4）:772-789.

［4］CHANG S,ROSENBERG M J,Morton H,et al.Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI［J］.Hum Mol Genet,1998,7（5）:865-870.

［5］EMMA. Glycogen Storage Disease Type VI [M]. Seattle(WA):University of Washington, Seattle,1993.(https://www.daowen.com)

［6］LU S Q,FENG J Y,LIU J,et al.Glycogen storage disease type VI can progress to cirrhosis:ten Chinese patients with GSD VI and a literature review ［J］.Pediatr Endocrinol Metab,2020,33（10）:1321-1333.

［7］TSILIANIDIS,L A ,FISKE L M ,SIEGEL S et al.Aggressive therapy improves cirrhosis in glycogen storage disease type IX［J］.Mol Genet Metab,2013,109:179-182.

［8］ROSCHER A,PATEL J,HEWSON S,et al.The natural history of glycogen storage disease types VI and IX:long-term outcome from the largest metabolic center in Canada［J］.Mol Genet Metab,2014,113:171-176.

（叶雅妹 林勇 林春 潘晨）